Faculty

Paul K. Drain

Adjunct Associate Professor, Epidemiology
Associate Professor, Global Health

206-520-3820

Education

MD Medicine (MD), University of Washington, 2007
MPH Epidemiology and International Health, University of Washington, 2001
BA Microbiology, Miami University (Ohio), 1996

Contact

206-520-3820

Box 359927
325 Ninth Ave
Seattle, WA 98104
View Website »

Bio

Paul Drain’s research group focuses on development, evaluation and implementation of diagnostic testing and clinic-based screening, including novel point-of-care technologies, to improve clinical care and patient-centered outcomes for tuberculosis and HIV in resource-limited settings. He is the Director of Clinical and Translational Research at the International Center for Clinical Research (ICRC) and the Director of the Clinical and Translational Science Core within the Tuberculosis Research Advancement Center (SEA-TRAC) at the University of Washington. He currently teaches “Global Population Health” in the School of Public Health, and teaches “Clinical Global Health and Social Medicine” for medical students. He research has been supported by several institutes of the National Institutes of Health, the Infectious Disease Society of America, Bill and Melinda Gates Foundation, the US Centers for Disease Control and Prevention, the US Department of Defense, the NIH Center for AIDS Research, as well as several corporations. He has authored several global health books and received awards from the Global Health Education Consortium, the Infectious Disease Society of America, and a Faculty Teaching Award from Harvard Medical School. Paul completed his medicine training at Stanford University and his infectious disease training at Massachusetts General Hospital and Brigham and Women’s Hospital at Harvard Medical School in Boston.

Research Areas

Research Interests

  • Infectious diseases
  • Improve the diagnosis and treatment for tuberculosis, HIV, and HIV-related opportunistic infections

Research Group Website

Recent Publications (PubMed)

Is Lenacapavir Needed for Individuals Adherent to Daily Oral PrEP?
(2024 Dec 1)
JAMA
Niu X, Drain PK
High burden of human papillomavirus and premalignant cervical lesions among women starting HIV treatment in KwaZulu-Natal, South Africa.
(2024 Nov 18)
Sex Transm Infect
Naicker N, Osman F, Naidoo K, Bodley N, Mbambo N, Madlala S, Mhlongo T, Mbatha N, Maphumulo A, Munatsi P, Radebe P, Liebenberg L, Dorward J, Drain PK, Garrett N
Urine lipoarabinomannan concentrations among HIV-negative adults with pulmonary or extrapulmonary tuberculosis disease in Vietnam.
(2024)
PLOS Glob Public Health 4(11): e0003891
Hoa NB, Fajans M, Nguyen Van H, Vu Ngoc B, Nguyen Viet N, Nguyen Thi H, Thi Huong LT, Tran Minh D, Nguyen Kim C, Thi Tuyet TH, Huu TN, Bui Ngoc D, Nguyen Viet H, Khanh AT, Lillis L, Perez M, Thomas KK, Peck RB, Cantera JL, Murphy E, Halas OR, Storey HL, Pinter A, Ruhwald M, Drain PK, Boyle DS
Factors that shape COVID-19 pediatric vaccine decision-making in rural agricultural communities: A qualitative study.
(2024 Dec 2)
Vaccine 42(26): 126389
Pascoe KM, Bishop S, Ci X, Ramirez M, Perez G, Ibarra G, Garza L, Linde S, Duran MC, Chae HY, Quigley T, Hassell L, Garrison MM, Drain PK, Shah PD, Ko LK
Real-world diagnostic accuracy of lipoarabinomannan in three non-sputum biospecimens for pulmonary tuberculosis disease.
(2024 Oct)
EBioMedicine 108(): 105353
Drain PK, Niu X, Shapiro AE, Magcaba ZP, Ngcobo Z, Ngwane MW, Thomas KK, Dalmat RR, Morton JF, Budiawan E, Pinter A, Cantera J, Anderson C, Buchmann R, Wilson D, Grant B, Prove-TB Study team
Show complete publication list